• 검색 결과가 없습니다.

Recent advance in inhaler medications for chronic obstructive pulmonary disease patients

N/A
N/A
Protected

Academic year: 2021

Share "Recent advance in inhaler medications for chronic obstructive pulmonary disease patients"

Copied!
4
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1.  Effective treatment in chronic obstructive pulmonary disease  Proven beneficial effect Survival Hospitalization Quality of
Figure 1.  Pharmacological treatment in chronic obstructive pulmonary disease (COPD) (From Korean  Academy of Tuberculosis and Respiratory Diseases

참조

관련 문서

1) Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Yates, B.S., Jørgen Vestbo, M.D.,

GRIPHON Prostacyclin (PGI2) Receptor Agonist In Pulmonary Arterial Hypertension IPAH idiopathic pulmonary arterial hypertension MCTD mixed connective tissue

Specifically, the prevalence and incidence rates of cancer among chronic diseases are continuously increasing, while early diagnosis and treatment of cancer

Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. Pulmonary embolism caused

Prevalence of sleep-disordered breathing in acute ischemic stroke as determined using a portable sleep apnea monitoring device in Korean subjects.. Obstructive

Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Detection of hepatitis C virus RNA

Cephalometric comparisons of craniofacial and upper airway structure by skeletal subtype and gender in patients with obstructive sleep apnea.. Nasal

Baseline characteristics of genotype 1b chronic hepatitis C patients who treated with daclatasvir and asunaprevir (n=231)... Characteristics of genotype 1b